OB
ORF Biologics, Inc.
SEC filingBiotechnology · Tiffin, IA
Amount raised$1.7Msold at filing
Total offering$2.5M$766K still open
Investors in the raise17count reported to the SEC
FiledJul 31, 2026first sale Jul 23, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jay KamathExecutive Officer
Sara TernesExecutive Officer
Roger A. BakerDirector
Anant KamathExecutive Officer, Director
Nicholas TaiberDirector
John R. HuiskampDirector
Steven MichalicekDirector
Executive officers, directors and promoters as listed on the Form D.